Security key
61023L108
- Security type / class
- Equity / COM
- Total 13F shares
- 187,361
- Total 13F value
- $1,104,123
- Share change
- -7,434
- SEC-reported price per share
- $5.89
- Number of holders
- 8
- Value change
- -$62,989
- Number of buys
- 5
- Number of sells
- 5
Report period
Q2 2021
Institutions
8
Top holders
8
MNPR full security history
Ownership snapshot
Full 13F holder table
Monopar Therapeutics SEC filings
Monopar Therapeutics company facts
Monopar Therapeutics 13D/G history
Broader feeds
Ownership snapshot
Top reported holders of MNPR - MONOPAR THERAPEUTICS INC - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MARSHALL WACE, LLP
Disclosed value leader
MARSHALL WACE, LLP
Comparable rows
0/12
Latest evidence
31 Mar 2021
13F
Highest disclosed value: $295,000
12 rows are not safely comparable across share classes.
Showing 1-6 of 12 holder rows.
Quick read
MARSHALL WACE, LLP has the largest disclosed position value at $295K.
0 of 12 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MARSHALL WACE, LLP's linked filing trail.
Disclosed position value
Top 5
MARSHALL WACE, LLP
$295K
VANGUARD GROUP INC
$279K
NORTHERN TRUST CORP
$223K
GEODE CAPITAL MANAGEMENT, LLC
$163K
CITADEL ADVISORS LLC
$77K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 12 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MARSHALL WACE, LLP |
13F
Company
|
—
denominator unverified
|
$295,000
47,653 shares
|
— | 31 Mar 2021 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$279,000
45,070 shares
|
— | 31 Mar 2021 |
| NORTHERN TRUST CORP |
13F
Company
|
—
denominator unverified
|
$223,000
36,001 shares
|
— | 31 Mar 2021 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$163,000
26,394 shares
|
— | 31 Mar 2021 |
| CITADEL ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$77,000
12,479 shares
|
— | 31 Mar 2021 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$70,000
11,229 shares
|
— | 31 Mar 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
8
Shares
187,361
Rows available
8
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
12
Q2 2021 holders
8
Holder diff
-4
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 value | Q2 2021 value | Value change | Value Chg % |
|---|